Pasithea Therapeutics Corp.

KTTA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.51

-$0.01 (-2.62%)

At close: Sep 21, 2026, 4:00 PM ET

$0.49

-$0.02 (-3.73%)

Pre-market: Sep 22, 2026, 4:27 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $17.5M

Enterprise Value $-45.65B

Beta 0.29

Average Volume 632.8K

Shares Outstanding (Diluted) 32.1M

Shares Change YoY 469.02%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US70261F2020

Price Performance

Price Change 1M -1.9%

Price Change 3M -10.2%

Price Change 6M -34.7%

Price Change YTD -57.1%

Price Change 1Y -30.1%

Price Change 3Y -94.2%

Price Change 5Y -99.1%

1M CAGR (ann.) 18.1%

1Y CAGR (ann.) -27.3%

5Y CAGR (ann.) N/A

All-Time CAGR -62.5%

Valuation

PE Ratio -0.27

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS N/A

PB Ratio 0.00

P/FCF Ratio -0.96

P/Adj. FCF Ratio -0.04

P/OCF Ratio -0.20

EV/Sales N/A

EV/EBIT 1,905.43

EV/EBITDA 1,958.92

EV/FCF 2,567.08

Earnings Yield -366.7%

FCF Yield -104.3%

Adj. FCF Yield -2457.9%

Financial Health

Net Cash $45.66B

Total Debt $0

Cash & Short-Term Investments $45.66B

Total Assets $51.71B

Current Ratio 26.25

Quick Ratio 26.25

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -2.11

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -2257.4%

Returns

Return on Assets -41.2%

Return on Equity -49.5%

Return on Invested Capital -48.0%

Return on Capital Employed -48.0%

Return on Tangible Assets 0.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 74.5%

EPS CAGR 5Y 43.1%

EPS CAGR 10Y N/A

FCF CAGR 3Y -9.6%

FCF CAGR 5Y -12.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.21

EPS Growth Est (next Q) -48.8%

Revenue Est (next Q) $200K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $3

Price Target Upside 488.2%

Cash Flow

Operating Cash Flow $-17.78M

Free Cash Flow $-17.78M

Adj. Free Cash Flow $-419.19M

FCF Per Share -$2.53

OCF Per Share -$2.53

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-473.04K

Operating Income $-23.96M

EBITDA $-23.3M

Net Income $-21.29M

EPS (Diluted) -$1.87

Revenue / Employee N/A

Profit / Employee $-4.26M

Employees 5